Loading news...
A director at ePlus Inc. sold over 500 shares in a direct open-market transaction on Dec. 8, 2025, with the total value of the sale going past $50k. The sale concludes a sequence of two direct sales since August 2024, with capacity constraints explaining the smaller transaction size relative to prior activity.
Allspring Global Investments Holdings LLC reduced its stake in shares of ePlus inc. (NASDAQ: PLUS) by 59.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,652 shares of the software maker's stock after selling 46,288 shares during the quarter. Allspring
HERNDON, Va., Jan. 6, 2026 /PRNewswire/ -- ePlus inc.
HERNDON, Va., Jan. 5, 2026 /PRNewswire/ -- ePlus inc.
ePlus inc.'s delivered strong growth across sales, billings, EBITDA, and net income in Q2 FY26 with gross billings crossing $1 billion for the first time, confirming scale momentum. ePlus' headline profitability looks strong, but cash generation lags due to working capital build, because accounts receivable and inventory has tied up significant cash since FY26 began. Narrowing the cash conversion cycle remains the key operational variable and will be the litmus test in FY26.
Squarepoint Ops LLC bought a new position in shares of ePlus inc. (NASDAQ: PLUS) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 17,668 shares of the software maker's stock, valued at approximately $1,274,000. Squarepoint Ops LLC owned approximately 0.07% of
HERNDON, Va., Dec. 16, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that CRN®, a brand of The Channel Company, has named Dori White, Vice President of Field and Partner Marketing, as Marketing Executive of the Year (Solution Provider) in the 2025 CRN Women of the Year Awards.
How investors can use a Zacks screen to help find some of the best Zacks Rank #1 (Strong Buy) stocks out of a group of over 200 highly-ranked companies to consider buying now.
Aviva PLC decreased its holdings in shares of ePlus inc. (NASDAQ: PLUS) by 26.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,756 shares of the software maker's stock after selling 2,475 shares during the quarter. Aviva PLC's holdings
It notched a beat-and-raise fiscal second quarter. It's also modeling double-digit increases in key fundamentals for the full fiscal year.
ePlus inc. ( PLUS ) Q2 2026 Earnings Call November 6, 2025 4:30 PM EST Company Participants Amanda Dupree Mark Marron - CEO, President & Director Elaine Marion - Chief Financial Officer Conference Call Participants Margaret Nolan - William Blair & Company L.L.C., Research Division Gregory Burns - Sidoti & Company, LLC Presentation Operator Good day, ladies and gentlemen.
Raises Fiscal 2026 Guidance Amid Double Digit Growth Year Over Year in Second Quarter Revenue, Gross Profit, Net Earnings and Earnings Per Share ~Announces Common Stock Quarterly Dividend of $0.25 Per Share ~ Second Quarter Fiscal Year 2026 Consolidated net sales increased 23.4% to $608.8 million; services revenues increased 19.4% to $123.8 million. Gross billings increased 26.5% to $1,022.7 million.
HERNDON, Va., Oct. 30, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that on November 6, 2025, it will release earnings and host a conference call regarding its financial results for the three and six months ended September 30, 2025. Earnings will be released after the market closes, and management will hold a conference call and audio webcast at 4:30 p.m. ET.
Nearly Three Out of Four IT and Industry Leaders Now Prioritize Revenue Growth as Main Driver of AI Initiatives, Over Cost Savings and Increased Customer Satisfaction HERNDON, Va. , Oct. 21, 2025 /PRNewswire/ -- ePlus inc.
Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.
Shares of clinical-stage pharmaceutical company, Plus Therapeutics, are up about 31% on a volume spike of 216.4 million
ePlus inc. (NASDAQ:PLUS ) Q1 2026 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Elaine D. Marion - Chief Financial Officer Kleyton L.
Transaction Enhances ePlus' AI-Powered Solutions Portfolio HERNDON, Va. , Sept. 10, 2025 /PRNewswire/ -- ePlus inc.
Shares in Plus500 Ltd (LSE:PLUS) dropped 5% today as some investors took profits after the company's interim results, which some commentators thought might contain an upgrade to forecasts. Despite this, the fintech's stock is still up 27.5% year to date.